Round Details
September 30, 2026 at 07:42 AM UTC
Scenario: Complex Appointment Booking - Coordinated Care
Patricia Davis, a 55-year-old female with newly diagnosed breast cancer (Stage IIA, ER+/PR+/HER2-), needs coordinated care setup. Her primary care physician Dr. Michael Thompson at Valley Medical Center is referring her to oncology for treatment planning. The patient needs: 1. An initial consultation with oncologist Dr. Jennifer Lee at Regional Cancer Center, scheduled for next Monday at 2:00 PM 2. Pre-consultation lab work (CBC, CMP, tumor markers) at the hospital lab, scheduled for this Friday at 9:00 AM 3. A follow-up mammogram and breast MRI at the imaging center, scheduled for next Tuesday at 10:30 AM 4. A second opinion consultation with surgical oncologist Dr. David Park, scheduled for next Wednesday at 3:00 PM The patient is currently taking Lisinopril 10mg daily for hypertension and Atorvastatin 20mg daily for hyperlipidemia. She has no known drug allergies. The referral includes her recent biopsy results, mammogram images, and pathology report. Insurance pre-authorization has been obtained for the oncology consultations.
How did the LLMs do?
Same LLM Tests
Reconstructed text
Patricia Davis is a 55-year-old woman with newly diagnosed, active, confirmed stage IIA breast cancer. Her receptor profile is estrogen receptor (ER) positive, progesterone receptor (PR) positive, and human epidermal growth factor receptor 2 (HER2) negative. Breast laterality, specific tumor site, staging system, and whether the stage is clinical or pathological were not specified. Her age is documented in the source narrative; no date of birth was provided.
She also has active, confirmed hypertension and hyperlipidemia. Her current medications are lisinopril 10 mg oral tablet once daily for hypertension and atorvastatin 20 mg oral tablet once daily for hyperlipidemia. She has no known drug allergies.
Her primary care physician, Dr. Michael Thompson of Valley Medical Center, has placed an active referral for an initial oncology consultation with Dr. Jennifer Lee at Regional Cancer Center for breast cancer treatment planning. This appointment is booked for next Monday at 2:00 PM. Supporting referral information includes the breast cancer receptor profile, current medications, allergy information, recent biopsy results, mammogram images, and a pathology report. The biopsy results and pathology report are also referenced as evidence for the cancer diagnosis. The actual document and image contents and their retrieval URLs were not provided.
Active, one-time orders for pre-consultation laboratory testing include a complete blood count with automated count, a comprehensive metabolic panel, and tumor markers, with the specific tumor-marker assays unspecified. These tests are scheduled for this Friday at 9:00 AM at a hospital laboratory; the hospital’s name was not provided. A follow-up mammogram and breast MRI are ordered for next Tuesday at 10:30 AM at an imaging center whose facility name was not provided. A second-opinion surgical oncology consultation with Dr. David Park is ordered for next Wednesday at 3:00 PM; its location was not specified.
Insurance preauthorization has been obtained for both the initial oncology consultation and the second-opinion surgical oncology consultation, with processing recorded as complete. The payer, authorization identifiers, authorization dates, and coverage details were not provided. All scheduling uses relative weekdays and local clock times; absolute calendar dates and time zones are unavailable, and the initial oncology appointment’s end time was not supplied. The provided JSON is truncated within the initial oncology appointment record, so this narrative reflects only the available information.
Comparison6 issues
Hallucinated:
- current medications and allergy information listed as part of the referrals supporting documents the original lists only biopsy results mammogram images and pathology report
- oral tablet formulation added for lisinopril and atorvastatin the original gives only dose and frequency 10mg daily 20mg daily
- lisinopril and atorvastatin are specified as oral tablets the original provides their doses and daily frequency but does not specify route or dosage form
- the cbc is specified as including an automated count the original requests a cbc without that additional detail
- laboratory testing is described as active onetime orders the original specifies scheduled testing but does not document order status or frequency
- the reconstruction claims that a provided json record is truncated within the initial oncology appointment no json record or truncation is described in the original
Reconstructed text
Patricia Davis is a 55-year-old female with a confirmed diagnosis of Stage IIA breast cancer (ER+/PR+/HER2-), active hypertension, and active hyperlipidemia. Breast cancer biomarker testing performed on June 1, 2025 demonstrated estrogen receptor positive, progesterone receptor positive, and HER2 negative status. She is currently prescribed lisinopril 10mg daily by mouth for hypertension and atorvastatin 20mg daily by mouth for hyperlipidemia, both ordered by her primary care physician, Dr. Michael Thompson at Valley Medical Center.
On June 10, 2025, Dr. Jennifer Lee (oncologist at Regional Cancer Center) ordered comprehensive laboratory testing including complete blood count, comprehensive metabolic panel, and tumor markers (CA 15-3 and CA 27.29) to be performed at Hospital Lab, as well as mammography and breast MRI to be performed at the Imaging Center. Dr. Thompson also initiated a referral to oncology with insurance pre-authorization obtained, including recent biopsy results, mammogram images, and pathology report.
The patient has the following upcoming appointments: laboratory procedures at Hospital Lab on June 13 from 09:00-10:00, oncology consultation with Dr. Lee at Regional Cancer Center on June 16 from 14:00-15:00, imaging studies at Imaging Center on June 17 from 10:30-12:00, and surgical oncology consultation with Dr. David Park at Regional Cancer Center on June 18 from 15:00-16:00.
Comparison17 issues
Missing information:
- no known drug allergies nkda
- dr david parks consultation is a second opinion the reconstruction describes it only as a surgical oncology consultation
- purpose of the oncology referral treatment planning for a newly diagnosed cancer
- the breast cancer is newly diagnosed
- the consultation with dr jennifer lee is an initial consultation for treatment planning
- the mammogram and breast mri are followup imaging
- the consultation with dr david park is specifically for a second opinion
Hallucinated:
- dr jennifer lee named as the ordering provider for the labs and imaging with an order date of june 10 2025 added
- tumor markers specified as ca 153 and ca 2729 the original says only tumor markers
- dr david park placed at regional cancer center the original gives no location for his consultation
- biomarker testing date of june 1 2025 added
- dr michael thompson named as the prescriber of lisinopril and atorvastatin the original does not say who prescribed them
- appointment end times and durations added labs until 1000 oncology until 1500 imaging until 1200 surgical oncology until 1600
- breast cancer biomarker testing is stated to have been performed on june 1 2025 the original provides receptor status but no testing date
- dr michael thompson is identified as the prescribing clinician for both medications the original does not identify their prescriber
- oral administration is specified for lisinopril and atorvastatin the original does not explicitly state an administration route
- the laboratory appointment is assigned june 13 2025 and an end time of 1000 am the original specifies only this friday at 900 am
Reconstructed text
No FHIR JSON came through with your message. Please paste it and I'll turn it into a clinical narrative.
The narrative will include:
- Demographics: name, birth date or age, gender, identifiers
- Allergies and intolerances, with reactions and severity
- Conditions and diagnoses, with clinical status and onset dates
- Medications, with exact dose, route, frequency, and status
- Observations, such as vitals and lab results with units and reference ranges
- Procedures, immunizations, and encounters
- Appointments: dates, times, providers, locations, and status
- Care plans, goals, and other resources in the bundle
I'll include only what's explicitly in the FHIR. For example, if gender isn't specified or only a birth year is given, I'll say so rather than guess.
Comparison22 issues
Missing information:
- initial oncology consultation with dr jennifer lee at regional cancer center next monday at 200 pm
- preconsultation lab work cbc cmp tumor markers at the hospital lab this friday at 900 am
- followup mammogram and breast mri at the imaging center next tuesday at 1030 am
- second opinion consultation with surgical oncologist dr david park next wednesday at 300 pm
- medication lisinopril 10mg daily
- no known drug allergies
- insurance preauthorization obtained for the oncology consultations
- patient name patricia davis
- age 55 years
- female gender
- diagnosis of newly diagnosed breast cancer stage iia
- receptor status erprher2
- referring primary care physician dr michael thompson at valley medical center
- referral to oncology for treatment planning and coordinated care setup
- condition hypertension
- referral includes recent biopsy results
- referral includes mammogram images
- patient identity and demographics patricia davis a 55yearold female
- newly diagnosed breast cancer stage iia with erpositive prpositive and her2negative receptor status
- need for coordinated care setup with primary care physician dr michael thompson at valley medical center referring the patient to oncology for treatment planning
- current medication atorvastatin 20 mg daily for hyperlipidemia
- referral includes recent biopsy results mammogram images and the pathology report
Cross LLM Tests
Reconstructed text
Patricia Davis is a 55-year-old female with no known drug allergies. She has active diagnoses of hypertension, hyperlipidemia, and newly diagnosed Stage IIA breast cancer, which is estrogen receptor (ER) positive, progesterone receptor (PR) positive, and HER2 negative. Her current medications include lisinopril 10mg daily for hypertension and atorvastatin 20mg daily for hyperlipidemia.
Dr. Michael Thompson, her primary care physician at Valley Medical Center, has referred her to Dr. Jennifer Lee, oncologist at Regional Cancer Center, for initial oncology consultation and treatment planning. This appointment is scheduled for next Monday at 2:00 PM at Regional Cancer Center. The referral includes supporting documentation: recent breast biopsy results, mammogram images, and a pathology report confirming the breast cancer diagnosis and receptor status. Insurance pre-authorization for the oncology consultation has been obtained.
Comparison4 issues
Missing information:
- preconsultation lab work cbc cmp tumor markers at the hospital lab scheduled for this friday at 900 am
- followup mammogram and breast mri at the imaging center scheduled for next tuesday at 1030 am
- second opinion consultation with surgical oncologist dr david park scheduled for next wednesday at 300 pm
- insurance preauthorization covers the oncology consultations plural the reconstruction limits it to a single consultation
Reconstructed text
Please provide the FHIR JSON you’d like me to convert into a human-readable clinical narrative.
Comparison21 issues
Missing information:
- patient name patricia davis
- referring primary care physician dr michael thompson at valley medical center
- initial oncology consultation with dr jennifer lee at regional cancer center next monday at 200 pm
- preconsultation lab work cbc cmp tumor markers at hospital lab this friday at 900 am
- followup mammogram and breast mri at imaging center next tuesday at 1030 am
- second opinion consultation with surgical oncologist dr david park next wednesday at 300 pm
- current medication lisinopril 10mg daily for hypertension
- no known drug allergies
- insurance preauthorization obtained for oncology consultations
- patient age 55 years
- patient sex female
- diagnosis of newly diagnosed breast cancer
- cancer stage iia
- receptor status erprher2
- need for coordinated care setup
- referral to oncology for treatment planning
- comorbidity of hypertension
- referral includes recent biopsy results
- referral includes mammogram images
- newly diagnosed stage iia breast cancer with erpositive prpositive her2negative receptor status
- the referral includes recent biopsy results mammogram images and the pathology report
Reconstructed text
No FHIR JSON came through with your message. Could you paste the resource or Bundle you'd like converted?
Once you share it, I'll write a paragraph narrative covering whatever the resources contain, such as:
- Demographics: name, birth date, gender, identifiers
- Conditions: diagnoses with clinical and verification status and onset dates
- Allergies: substances, reactions, severity, status
- Medications: drug names, doses, routes, frequencies, status
- Encounters and appointments: dates, times, locations, practitioners, reasons
- Observations and procedures: lab results, vital signs, procedures performed
- Care plans and other resources: goals, instructions, and related details
I'll include only information that is explicitly in the FHIR. For example, I won't infer gender if the Patient resource doesn't specify it, and I'll report a partial birth date (such as a year only) as given rather than calculating an exact age.
Comparison23 issues
Missing information:
- need for coordinated care setup
- referring primary care physician dr michael thompson at valley medical center
- initial oncology consultation with dr jennifer lee at regional cancer center next monday at 200 pm
- preconsultation lab work cbc cmp tumor markers at the hospital lab this friday at 900 am
- followup mammogram and breast mri at the imaging center next tuesday at 1030 am
- second opinion consultation with surgical oncologist dr david park next wednesday at 300 pm
- medication lisinopril 10mg daily
- no known drug allergies
- insurance preauthorization obtained for the oncology consultations
- patient name patricia davis
- age 55 years
- female gender
- diagnosis of newly diagnosed breast cancer
- cancer stage iia
- receptor status erprher2
- referral to oncology for treatment planning
- hypertension diagnosis
- referral includes recent biopsy results
- referral includes mammogram images
- patient identity and demographics patricia davis a 55yearold female
- newly diagnosed breast cancer stage iia with erpositive prpositive and her2negative receptor status
- current medication atorvastatin 20 mg daily for hyperlipidemia
- the referral includes recent biopsy results mammogram images and the pathology report